Osimertinib-associated erythema dyschromicum perstans-like eruption: A case series

Christina S Oh; Michael J Martinez; Shane Meehan; Daniel Gutierrez; Ian W Tattersall

doi:10.1016/j.jdcr.2023.01.038

Osimertinib-associated erythema dyschromicum perstans-like eruption: A case series

JAAD Case Rep. 2023 Mar 7:35:28-32. doi: 10.1016/j.jdcr.2023.01.038. eCollection 2023 May.

Authors

Christina S Oh¹, Michael J Martinez¹, Shane Meehan¹, Daniel Gutierrez¹, Ian W Tattersall¹

Affiliation

¹ Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, New York.

No abstract available

Keywords: ashy dermatosis; epidermal growth factor receptor tyrosine kinase inhibitor; erythema dyschromicum perstans; hyperpigmentation; osimertinib..

Publication types

Case Reports